We found that miR-30c ameliorated cardiac metabolism disorders in DCM via peroxisome proliferator-activated receptor-gamma coactivator-1 beta (PGC-1β)/peroxisome proliferator-activated receptor alpha (PPARα) signaling [18]. Here, PPARGC1B is linked to familial dilated cardiomyopathy.